HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation

BACKGROUND: The introduction of direct-acting antivirals (DAA) for HCV has led to high rates of HCV eradication. Treatment of patients awaiting liver transplantation (LT) has been controversial. Recent data suggests that DAA treatment may accelerate recurrent HCC. The impact of DAA on delisting for...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Can J Gastroenterol Hepatol
Prif Awduron: Emamaullee, Juliet A., Bral, Mariusz, Meeberg, Glenda, Montano-Loza, Aldo J., Bain, Vincent G., Burak, Kelly Warren, Bigam, David, Shapiro, A. M. James, Kneteman, Norman
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354133/
https://ncbi.nlm.nih.gov/pubmed/30775356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2509059
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg